Literature DB >> 10428941

Stability of antibiotics used for antibiotic-lock treatment of infections of implantable venous devices (ports).

T U Anthony1, L G Rubin.   

Abstract

Antibiotic-lock is a treatment for catheter-related bloodstream infections in which a solution containing heparin and an antibiotic dwells in the lumen of the catheter or port. We tested the stability of vancomycin, cefazolin, ticarcillin-clavulanic acid, ceftazidime, or ciprofloxacin combined with heparin after incubation in vitro at 25 or 37 degrees C for intervals of up to 10 days by bioassay. All the antibiotic solutions except ceftazidime retained >/=90% activity at both 25 and 37 degrees C. Thus, studies of antibiotic-heparin lock solutions with dwell times of up to 10 days are feasible.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10428941      PMCID: PMC89419     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Cure of implantable venous port-associated bloodstream infections in pediatric hematology-oncology patients without catheter removal.

Authors:  L G Rubin; S Shih; A Shende; G Karayalcin; P Lanzkowsky
Journal:  Clin Infect Dis       Date:  1999-07       Impact factor: 9.079

2.  A dilute solution of vancomycin and heparin retains antibacterial and anticoagulant activities.

Authors:  K J Henrickson; K R Powell; C L Schwartz
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

Review 3.  Intravenous catheter-related infections.

Authors:  M B Salzman; L G Rubin
Journal:  Adv Pediatr Infect Dis       Date:  1995

4.  Conventional and nonconventional modes of vancomycin administration to decontaminate the internal surface of catheters colonized with coagulase-negative staphylococci.

Authors:  J L Gaillard; R Merlino; N Pajot; O Goulet; J L Fauchere; C Ricour; M Veron
Journal:  JPEN J Parenter Enteral Nutr       Date:  1990 Nov-Dec       Impact factor: 4.016

5.  A new approach to the management of Broviac catheter infection.

Authors:  J S Rao; A O'Meara; T Harvey; F Breatnach
Journal:  J Hosp Infect       Date:  1992-10       Impact factor: 3.926

6.  Infectious morbidity associated with long-term use of venous access devices in patients with cancer.

Authors:  J S Groeger; A B Lucas; H T Thaler; H Friedlander-Klar; A E Brown; T E Kiehn; D Armstrong
Journal:  Ann Intern Med       Date:  1993-12-15       Impact factor: 25.391

7.  Intraluminal antibiotic treatment of central venous catheter infections in patients receiving parenteral nutrition at home.

Authors:  J L Benoit; G Carandang; M Sitrin; P M Arnow
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

Review 8.  Central venous catheter infections.

Authors:  M D Decker; K M Edwards
Journal:  Pediatr Clin North Am       Date:  1988-06       Impact factor: 3.278

9.  Treatment of Hickman catheter sepsis using antibiotic lock technique.

Authors:  E A Krzywda; D A Andris; C E Edmiston; E J Quebbeman
Journal:  Infect Control Hosp Epidemiol       Date:  1995-10       Impact factor: 3.254

10.  Antibiotic-lock technique: a new approach to optimal therapy for catheter-related sepsis in home-parenteral nutrition patients.

Authors:  B Messing; S Peitra-Cohen; A Debure; M Beliah; J J Bernier
Journal:  JPEN J Parenter Enteral Nutr       Date:  1988 Mar-Apr       Impact factor: 4.016

View more
  13 in total

1.  Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.

Authors:  Leonard A Mermel; Michael Allon; Emilio Bouza; Donald E Craven; Patricia Flynn; Naomi P O'Grady; Issam I Raad; Bart J A Rijnders; Robert J Sherertz; David K Warren
Journal:  Clin Infect Dis       Date:  2009-07-01       Impact factor: 9.079

2.  A simplified method of antibiotic lock therapy for Broviac-Hickman catheters using a CLC 2000 connector device.

Authors:  Simone Cesaro; Mara Cavaliere; Monica Spiller; Lucia Rossi; Laura Magagna; Patrizia Gavin; Michela Bonetto; Modesto Carli
Journal:  Support Care Cancer       Date:  2006-07-01       Impact factor: 3.603

3.  Vancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports: simplifying treatment of port-associated bloodstream infections by using the antibiotic lock technique.

Authors:  Y Haimi-Cohen; N Husain; J Meenan; G Karayalcin; M Lehrer; L G Rubin
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

4.  Semimechanistic pharmacokinetic-pharmacodynamic model with adaptation development for time-kill experiments of ciprofloxacin against Pseudomonas aeruginosa.

Authors:  Nicolas Grégoire; Sophie Raherison; Claire Grignon; Emmanuelle Comets; Manuella Marliat; Marie-Cécile Ploy; William Couet
Journal:  Antimicrob Agents Chemother       Date:  2010-04-05       Impact factor: 5.191

5.  In Vitro Study To Evaluate the Bioactivity of Freezing a Heparin-Based Dalbavancin Lock Solution.

Authors:  Marta Rubia; Andrea Cordero; María Jesús Pérez-Granda; Emilia Cercenado; Cristina Pascual; Patricia Muñoz; María Guembe
Journal:  Antimicrob Agents Chemother       Date:  2020-11-17       Impact factor: 5.191

6.  Prophylaxis of catheter-related bacteremia using tissue plasminogen activator-tobramycin locks.

Authors:  Ali Mirza Onder; Jayanthi Chandar; Anthony Billings; Nancy Simon; JoAnn Gonzalez; Denise Francoeur; Carolyn Abitbol; Gaston Zilleruelo
Journal:  Pediatr Nephrol       Date:  2009-07-10       Impact factor: 3.714

7.  Treatment of catheter-related bacteremia with tissue plasminogen activator antibiotic locks.

Authors:  Ali Mirza Onder; Jayanthi Chandar; Nancy Simon; Marie Saint-Vil; Denise Francoeur; Obioma Nwobi; Carolyn Abitbol; Gaston Zilleruelo
Journal:  Pediatr Nephrol       Date:  2007-12-06       Impact factor: 3.714

8.  Comparison of early versus late use of antibiotic locks in the treatment of catheter-related bacteremia.

Authors:  Ali Mirza Onder; Jayanthi Chandar; A A Billings; Nancy Simon; Rosa Diaz; Denise Francoeur; Carolyn Abitbol; Gaston Zilleruelo
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-09       Impact factor: 8.237

9.  Decreasing gradient of antibiotic concentration in the lumen of catheters locked with vancomycin.

Authors:  A Soriano; E Bregada; J M Marqués; M Ortega; A Bové; J A Martínez; J Mensa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-09       Impact factor: 3.267

10.  Anticoagulant properties of enoxaparin 400 IU/mL-40 % ethanol catheter lock solution.

Authors:  Laure Calvet; Michèle Piot; Claire Lartigue; Bertrand Souweine; Brigitte Tardy-Poncet
Journal:  Springerplus       Date:  2015-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.